Oligomeric bile acid-mediated oral delivery of low molecular weight heparin

Taslim A. Al-Hilal, Jooho Park, Farzana Alam, Seung Woo Chung, Jin Woo Park, Kwang Meyung Kim, Ick Chan Kwon, In-San Kim, Sang Yoon Kim, Youngro Byun

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Intestinal transporters are limited to the transport of small molecular substrates. Here, we describe the development of apical sodium-dependent bile acid transporter (ASBT)-targeted high-affinity oligomeric bile acid substrates that mediate the transmembrane transport of low molecular weight heparin (LMWH). Several oligomers of deoxycholic acid (oligoDOCA) were synthesized to investigate the substrate specificity of ASBT. To see the binding of oligoDOCA on the substrate-binding pocket of ASBT, molecular docking was used and the dissociation rate constants (KD) were measured using surface plasmon resonance. The KD for tetrameric DOCA (tetraDOCA) was 50-fold lower than that for monomeric DOCA, because tetraDOCA interacted with several hydrophobic grooves in the substrate-binding pocket of ASBT. The synthesized oligoDOCA compounds were subsequently chemically conjugated to macromolecular LMWH. In vitro, tetraDOCA-conjugated LMWH (LHe-tetraD) had highest selectivity for ASBT during its transport. Orally administered LHe-tetraD showed remarkable systemic anticoagulation activity and high oral bioavailability of 33.5 ± 3.2% and 19.9 ± 2.5% in rats and monkeys, respectively. Notably, LHe-tetraD successfully prevented thrombosis in a rat model of deep vein thrombosis. These results represent a major advancement in ASBT-mediated LMWH delivery and may facilitate administration of many important therapeutic macromolecules through a non-invasive oral route.

Original languageEnglish
Pages (from-to)17-24
Number of pages8
JournalJournal of Controlled Release
Volume175
Issue number1
DOIs
Publication statusPublished - 2014 Feb 10
Externally publishedYes

Fingerprint

Low Molecular Weight Heparin
Bile Acids and Salts
Desoxycorticosterone Acetate
Deoxycholic Acid
Surface Plasmon Resonance
Substrate Specificity
Venous Thrombosis
Biological Availability
Haplorhini
sodium-bile acid cotransporter
Thrombosis

Keywords

  • Bile acid conjugate
  • Bile acid transporter
  • Heparin
  • Oral delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Oligomeric bile acid-mediated oral delivery of low molecular weight heparin. / Al-Hilal, Taslim A.; Park, Jooho; Alam, Farzana; Chung, Seung Woo; Park, Jin Woo; Kim, Kwang Meyung; Kwon, Ick Chan; Kim, In-San; Kim, Sang Yoon; Byun, Youngro.

In: Journal of Controlled Release, Vol. 175, No. 1, 10.02.2014, p. 17-24.

Research output: Contribution to journalArticle

Al-Hilal, TA, Park, J, Alam, F, Chung, SW, Park, JW, Kim, KM, Kwon, IC, Kim, I-S, Kim, SY & Byun, Y 2014, 'Oligomeric bile acid-mediated oral delivery of low molecular weight heparin', Journal of Controlled Release, vol. 175, no. 1, pp. 17-24. https://doi.org/10.1016/j.jconrel.2013.12.001
Al-Hilal, Taslim A. ; Park, Jooho ; Alam, Farzana ; Chung, Seung Woo ; Park, Jin Woo ; Kim, Kwang Meyung ; Kwon, Ick Chan ; Kim, In-San ; Kim, Sang Yoon ; Byun, Youngro. / Oligomeric bile acid-mediated oral delivery of low molecular weight heparin. In: Journal of Controlled Release. 2014 ; Vol. 175, No. 1. pp. 17-24.
@article{bbe975f2ab5b48f1a0ce62ac8dda513e,
title = "Oligomeric bile acid-mediated oral delivery of low molecular weight heparin",
abstract = "Intestinal transporters are limited to the transport of small molecular substrates. Here, we describe the development of apical sodium-dependent bile acid transporter (ASBT)-targeted high-affinity oligomeric bile acid substrates that mediate the transmembrane transport of low molecular weight heparin (LMWH). Several oligomers of deoxycholic acid (oligoDOCA) were synthesized to investigate the substrate specificity of ASBT. To see the binding of oligoDOCA on the substrate-binding pocket of ASBT, molecular docking was used and the dissociation rate constants (KD) were measured using surface plasmon resonance. The KD for tetrameric DOCA (tetraDOCA) was 50-fold lower than that for monomeric DOCA, because tetraDOCA interacted with several hydrophobic grooves in the substrate-binding pocket of ASBT. The synthesized oligoDOCA compounds were subsequently chemically conjugated to macromolecular LMWH. In vitro, tetraDOCA-conjugated LMWH (LHe-tetraD) had highest selectivity for ASBT during its transport. Orally administered LHe-tetraD showed remarkable systemic anticoagulation activity and high oral bioavailability of 33.5 ± 3.2{\%} and 19.9 ± 2.5{\%} in rats and monkeys, respectively. Notably, LHe-tetraD successfully prevented thrombosis in a rat model of deep vein thrombosis. These results represent a major advancement in ASBT-mediated LMWH delivery and may facilitate administration of many important therapeutic macromolecules through a non-invasive oral route.",
keywords = "Bile acid conjugate, Bile acid transporter, Heparin, Oral delivery",
author = "Al-Hilal, {Taslim A.} and Jooho Park and Farzana Alam and Chung, {Seung Woo} and Park, {Jin Woo} and Kim, {Kwang Meyung} and Kwon, {Ick Chan} and In-San Kim and Kim, {Sang Yoon} and Youngro Byun",
year = "2014",
month = "2",
day = "10",
doi = "10.1016/j.jconrel.2013.12.001",
language = "English",
volume = "175",
pages = "17--24",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Oligomeric bile acid-mediated oral delivery of low molecular weight heparin

AU - Al-Hilal, Taslim A.

AU - Park, Jooho

AU - Alam, Farzana

AU - Chung, Seung Woo

AU - Park, Jin Woo

AU - Kim, Kwang Meyung

AU - Kwon, Ick Chan

AU - Kim, In-San

AU - Kim, Sang Yoon

AU - Byun, Youngro

PY - 2014/2/10

Y1 - 2014/2/10

N2 - Intestinal transporters are limited to the transport of small molecular substrates. Here, we describe the development of apical sodium-dependent bile acid transporter (ASBT)-targeted high-affinity oligomeric bile acid substrates that mediate the transmembrane transport of low molecular weight heparin (LMWH). Several oligomers of deoxycholic acid (oligoDOCA) were synthesized to investigate the substrate specificity of ASBT. To see the binding of oligoDOCA on the substrate-binding pocket of ASBT, molecular docking was used and the dissociation rate constants (KD) were measured using surface plasmon resonance. The KD for tetrameric DOCA (tetraDOCA) was 50-fold lower than that for monomeric DOCA, because tetraDOCA interacted with several hydrophobic grooves in the substrate-binding pocket of ASBT. The synthesized oligoDOCA compounds were subsequently chemically conjugated to macromolecular LMWH. In vitro, tetraDOCA-conjugated LMWH (LHe-tetraD) had highest selectivity for ASBT during its transport. Orally administered LHe-tetraD showed remarkable systemic anticoagulation activity and high oral bioavailability of 33.5 ± 3.2% and 19.9 ± 2.5% in rats and monkeys, respectively. Notably, LHe-tetraD successfully prevented thrombosis in a rat model of deep vein thrombosis. These results represent a major advancement in ASBT-mediated LMWH delivery and may facilitate administration of many important therapeutic macromolecules through a non-invasive oral route.

AB - Intestinal transporters are limited to the transport of small molecular substrates. Here, we describe the development of apical sodium-dependent bile acid transporter (ASBT)-targeted high-affinity oligomeric bile acid substrates that mediate the transmembrane transport of low molecular weight heparin (LMWH). Several oligomers of deoxycholic acid (oligoDOCA) were synthesized to investigate the substrate specificity of ASBT. To see the binding of oligoDOCA on the substrate-binding pocket of ASBT, molecular docking was used and the dissociation rate constants (KD) were measured using surface plasmon resonance. The KD for tetrameric DOCA (tetraDOCA) was 50-fold lower than that for monomeric DOCA, because tetraDOCA interacted with several hydrophobic grooves in the substrate-binding pocket of ASBT. The synthesized oligoDOCA compounds were subsequently chemically conjugated to macromolecular LMWH. In vitro, tetraDOCA-conjugated LMWH (LHe-tetraD) had highest selectivity for ASBT during its transport. Orally administered LHe-tetraD showed remarkable systemic anticoagulation activity and high oral bioavailability of 33.5 ± 3.2% and 19.9 ± 2.5% in rats and monkeys, respectively. Notably, LHe-tetraD successfully prevented thrombosis in a rat model of deep vein thrombosis. These results represent a major advancement in ASBT-mediated LMWH delivery and may facilitate administration of many important therapeutic macromolecules through a non-invasive oral route.

KW - Bile acid conjugate

KW - Bile acid transporter

KW - Heparin

KW - Oral delivery

UR - http://www.scopus.com/inward/record.url?scp=84891528616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891528616&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2013.12.001

DO - 10.1016/j.jconrel.2013.12.001

M3 - Article

C2 - 24333628

AN - SCOPUS:84891528616

VL - 175

SP - 17

EP - 24

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 1

ER -